SUMMARY In 21 patients with multiple sclerosis and 20 healthy controls, the following tests of autonomic function were examined: (1) variation in heart rate during deep breathing, (2) the variations in heart rate and systolic blood pressure during a standardised Valsalva manoeuvre, (3) the changes in heart rate and systolic blood pressure during arm ergometry starting at 30 W with increments of 20 W every 3 min. In the control subjects the maximum variation in heart rate from inspiration to expiration was >16 beat/min (range 17-43). In patients with multiple sclerosis, five had a maximum variation in heart rate of <13 beat/min which was considered as the lower limit of normal. The Valsalva ratio in the control subjects ranged from 1-33-3-24. Four patients had Valsalva ratios of <1-30. In patients with multiple sclerosis the heart rate and systolic blood pressure responses to exercise were attenuated significantly in four and seven subjects respectively. It is concluded that a significant number of patients with multiple sclerosis show evidence of autonomic dysfunction involving the cardiovascular system. It is well known that multiple sclerosis can lead to dysfunction of the autonomic nervous system. Thus bladder dysfunction leading to retention of urine and incontinence and sexual dysfunction leading to impotence are relatively common clinical features in patients with this disease. The manifestations of this autonomic nerve dysfunction as it affects the organs of the pelvis, especially the bladder, have been investigated in detail.'2 However, there are relatively few reports on the cardiovascular manifestations of this condition.34
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In a study of 50 patients with multiple sclerosis, Cartlidge3 reported no evidence of postural hypotension or abnormal blood pressure responses to exercise. In patients at rest, Neubauer and Gundersen4 observed a reduction in the variations of the heart rate with respiration, which they attributed to dysfunction of the autonomic control of the heart and circulation. The present investigation was Twenty healthy subjects (controls) and 21 patients with multiple sclerosis were studied. All the subjects were informed of the aims of the study and agreed to participate in it. The controls were hospital personnel with no known history or symptoms suggestive of diabetes mellitus, cardiovascular or renal disease. There were nine men and 11 women in this group and their ages ranged from 22-51 years (mean 37-8 years). There were 13 men and eight women in the Patient Group. In this latter group the diagnosis of multiple sclerosis had been established on the basis of Schumacher's criteria. 5 [8] [9] [10] consecutive breaths in each subject. From these recordings the difference between the maximum and minimum heart rates during deep breathing was measured for each respiratory (that is inspiratory-expiratory) cycle.
From this data the following " measurements" were determined: 1. The maximum variation in heart rate from inspiration to expiration in any single respiratory cycle (MVHR). A MVHR of less than 13 beats per minute was considered abnormal.6 2. The average variation in heart rate from inspiration to expiration for all the respiratory cycles during the period of deep breathing (AVHR). 3 . The average maximum and minimum heart rates during inspiration and expiration expressed as a ratio (I:E).
I.E = Mean Value for Maimum Heart Rate During Each Inspirtion Mean Value for Minimum Heart Rate During Each Expiration This ratio is numerically identical to the "E: I ratio" described by Sundkvist et al7 who based their calculations on the maximum and minimum R-R intervals.
(b) Valsalva manoeuvre8 9 The subjects were asked to blow into a mercury manometer and maintain a pressure of 40 mm Hg for 15 seconds. The ECG was recorded before, during and for 30 seconds after the manoeuvre. The blood pressure was measured before, during the final 5 seconds of the "strain" and after Senaratne, Carroll, Warren, Kappagoda resumption of normal breathing.
The Valsalva Ratio which is the maximum heart rate during the manoeuvre divided by the minimum heart rate after resuming spontaneous respiration was calculated.
The recordings of both the above tests were taken after a period of "training' during which the subjects familiarised themselves with the apparatus. This training varied from one to several trials depending on the subject. Patients who were unable to perform the tests satisfactorily (because of incoordination, etc.) were not tested. Any tests considered as abnormal were repeated for confirmation.
(c) Arm ergometry The subjects were exercised in an electrically braked arm ergometer (Model EO 22 E1852, Siemans Elema). Arm ergometry was adopted as the preferred form of exercise for this study as the majority of the patients with multiple sclerosis were disabled to a lesser degree in their upper limbs than in the lower limbs. The exercise was started with a load of 30 watts (W) and increased by 20 W every 3 min. It was terminated when the patients were unable to continue the activity without discomfort. The ECG was monitored continuously and the average heart rate during the 3rd minute of each stage of exercise was used in the analysis. The blood pressure was recorded using a sphygmomanometer during the 3rd minute of each stage. The responses to exercise were assessed by plotting the values of heart rate and systolic blood pressure against the load.
STATISTICAL METHODS '°T he data from the patient and control groups were compared by means of the Wilcoxan' s rank sum test for unpaired data. The Spearman' s rank correlation coefficient (rs) was calculated for the correlation analyses. A p value of <0-05 was taken as significant. These non-parametric tests were selected in order to avoid the assumption that the data had a normal distribution. The heart rate and systolic blood pressure responses to exercise during arm ergometry were defined by linear regression analysis against the load in watts. As an index of the rate of rise of the systolic blood pressure and heart rate during exercise, the average increases per 20 watt increment in load were calculated for each subject investigated.
Results
The patients consisted of 13 males and eight females and the mean age was 41 0 years (range 28-58). The mean duration of the disease (from the initial diagnosis) was 11-7 years (SEM 2*2, range 1-25 years subjects and 11 patients. All the control subjects tested showed sinus arrythmia of varying magnitude during quiet breathing. The variations in heart rate associated with inspiration and expiration increased markedly during deep breathing. The MVHR during deep breathing was 25-7 beat/min (mean; SEM 1.5). The lowest value observed in these subjects was 17 beat/min. The AVHR in the control subjects was 21-0 beat/min (mean; SEM 1D4; range 12-3-36.5). The I:E. ratio in these subjects was 1-35 (mean; SEM 0-02; range 1-21-1.58). Of the three criteria only the AVHR had a significant negative correlation with the age of the control subjects with an rs value of -0-59 (p < 0.05).
In the 11 patients in whom the deep breathing tests were done the MVHR was 12-0 beat/min (mean; SEM 09, range 8-16) with six patients having a MVHR of less than 13 beat/min. The AVHR in these 11 patients was 9-4 beat/min (mean; SEM 0-9, range 4-2-13.1). The lowest six values of the AVHR were obtained in the six patients with a MVHR of less than 13 beat/min. The I: E ratio in the patients was 1.12 (mean; SEM 0-01, range 1-07-1-18).
Of the three criteria examined, the I:E ratio and the AVHR had significant negative correlations with the age of the patients with rs values of -0-61 and -0-53 respectively (p < 0.05). 3 The regression analysis for the systolic blood pressure (SBP-mmHg) and heart rate (heart rate-beatlmin) responses to exercise. Interrupted lines represent the 95 % confidence intervals. Examples ofsystolic blood pressure and heart rate responses ofpatients who were considered as abnormal are shown (refer text for explanation).
Also none of the three criteria was correlated significantly with the duration of the illness (p > 0-05). The data for the 11 patients are summarised in fig 1. As a group the patients were significantly different from the controls in all three criteria tested (p < 0-01). All the control subjects tested showed a characteristic response to the Valsalva manoeuvre with a drop in systolic blood pressure and a tachycardia during the period of strain and an increase in systolic blood pressure above control levels with a reflex bradycardia after resumption of normal respiration. In the control subjects, the Valsalva ratio was greater than 1*3 (range 1*33-3-24). Of the 19 patients tested, four had a Valsalva ratio of 1-3 or less. Three of these patients had no overshoot in the systolic blood pressure after resumption of normal respiration. Of the six patients who had abnormal responses to deep breathing only one had a Valsalva ratio of less than 1-3. There was no significant correlation between the Valsalva ratio and the AVHR, the MVHR or the I:E ratio (p > 0-05). The Valsalva ratios of the patients were not significantly different from those of the controls (p > 0-05).
(c) Arm ergometry The 20 control subjects exercised on the arm ergometer until they were unable to continue without distress. The maximum load achieved had a mode of 70 W (10 subjects) with a range from 50-130 W. The heart rate and systolic blood pressure rose in all subjects with exercise. Both the heart rate and systolic blood pressure had a significant correlation (p < 0.001) with the load (correlation coefficients +0X81 and +0-81 respectively). These results are summarised in fig 3. It was found that in the control group (n = 20), the minimum increase in systolic blood pressure and heart rate per 20 W increments in load, were 8-9 mm Hg and 12 beat/ min respectively (fig 4) . 
Evidence for cardiovascular autonomic nerve dysfunction in multiple sclerosis
The maximum load achieved by the 21 patients with multiple sclerosis had a mode of 70 W (seven subjects) with a range of 30-110 W. Five patients were able to complete the first stage of exercise only. Seven patients failed to achieve the minimum increase in systolic blood pressure (in the control subjects) with a 20 W increment in load, and four patients failed to achieve the corresponding increase in heart rate (fig 4) . Three of the latter group also failed to increase their blood pressure during exercise. Examples of responses that were considered as abnormal are shown in fig 3. None of the patients with multiple sclerosis experienced any adverse changes in their clinical status as a result of the exercise performed for the study. Of the six patients who had an MVHR of less than 13 beat/min, the systolic blood pressure response to exercise was abnormal in two and the heart rate in one.
One patient (BS) had two arm ergometry tests during two clinically different relapses with a gap of 3 months in between. The subject was recovering from a relapse with predominantly brain stem manifestations when he was tested initially. The systolic blood pressure and heart rate responses to exercise were clearly attenuated (changes in systolic blood pressure and heart rate per 20 W increment in load were -0*4 mm Hg and +9-6 beatlmin respectively) although the patient was able to exercise up to 110 watts at this time. After a relatively complete remission of 3 '4 In addition, it is conceivable that "the Group IV afferents" from the respiratory muscles could also make a contribution to this phenomenon. '5 (See below) . The findings obtained during exercise present an interesting area for speculation. It is apparent that a significant proportion of the patients examined revealed an attenuation of the heart rate and blood pressure responses to exercise. These effects could be viewed as yet another manifestation of a disturbance in the autonomic innervation. Hilsted'6 '' has reported abnormalities in the blood pressure and heart rate responses to exercise in patients with autonomic dysfunction of diabetic aetiology. These changes were associated with a reduction in the catecholamine responses to exercise also. The findings in the present study in relation to arm ergometry could be explained by a similar phenomenon.
However, there is an alternative possibility which should be considered. Longhurst and Mitchell '5 have reviewed recently the role of afferent impulses originating from skeletal muscles in the regulation of the heart rate and blood pressure during exercise.
The "Group IV afferents" are non-myelinated 952 nerves which appear to respond to metabolites generated in skeletal muscle during exercise. Activation of these fibres results in a reflex tachycardia and an increase in blood pressure. Whilst the precise central connections of these fibres remains in doubt, it is widely believed that these afferent impulses are conveyed to higher centres in the posterior columns of the spinal cord. As lesions in the posterior columns are frequent in multiple sclerosis, it is possible, that in some patients with this disease, a disturbance of this particular afferent pathway could result in an abnormal cardiovascular response to exercise.
In conclusion, this study has shown that a significant proportion of patients with multiple sclerosis have evidence of autonomic dysfunction affecting the cardiovascular system. These abnormalities could be demonstrated by the simple procedures described here. Apart from the one example described in this paper, there appears to be no definitive information available about the evolution of these abnormalities. Thus, follow-up investigations are being undertaken on this group of patients for the purpose of obtaining this information. It is conceivable that like the other clinical manifestations of multiple sclerosis, these signs of autonomic dysfunction also could alter in their severity with time.
